124 related articles for article (PubMed ID: 26468334)
1. The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine.
Gorodetska I; Serga S; Levkovich N; Lahuta T; Ostapchenko L; Demydov S; Anikusko N; Cheshuk V; Smolanka I; Sklyar S; Polenkov S; Boichenko O; Kozeretska I
Hered Cancer Clin Pract; 2015; 13():19. PubMed ID: 26468334
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.
Gorodetska I; Serga S; Lahuta T; Ostapchenko L; Demydov S; Khranovska N; Skachkova O; Inomistova M; Kolesnik O; Svintsitsky V; Tsip N; Peresunko A; Kmit' N; Manzhura O; Rossokha Z; Popova O; Salomakhina H; Kyriachenko S; Kozeretska I
Fam Cancer; 2017 Oct; 16(4):471-476. PubMed ID: 28285342
[TBL] [Abstract][Full Text] [Related]
3. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Rozite S; Bitina M; Keire G; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
BMC Med Genet; 2011 Oct; 12():147. PubMed ID: 22032251
[TBL] [Abstract][Full Text] [Related]
5. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
Cherdyntseva NV; Pisareva LF; Ivanova AA; Panferova YV; Malinovskaya EA; Odintsova IN; Doroshenko AV; Gervas PA; Slonimskaya EM; Shivit-ool AA; Dvornichenko VV; Choinzonov YL
Vestn Ross Akad Med Nauk; 2014; (11-12):72-9. PubMed ID: 25971130
[TBL] [Abstract][Full Text] [Related]
6. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
Samusieva A; Serga S; Klymenko S; Rybchenko L; Klimuk B; Zakhartseva L; Gorovenko N; Lobanova O; Rossokha Z; Fishchuk L; Levkovich N; Medvedieva N; Popova O; Cheshuk V; Inomistova M; Khranovska N; Skachkova O; Michailovich Y; Ponomarova O; Kozeretska I
Breast Cancer Res Treat; 2022 Oct; 195(3):453-459. PubMed ID: 35930098
[TBL] [Abstract][Full Text] [Related]
7. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
Hamel N; Kotar K; Foulkes WD
BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
Ławniczak M; Jakubowska A; Białek A; Lubiński J; Jaworska-Bieniek K; Kaczmarek K; Starzyńska T
Hered Cancer Clin Pract; 2016; 14():3. PubMed ID: 26779294
[TBL] [Abstract][Full Text] [Related]
9. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 5382insC founder mutation has not a significative recurrent presence in Northeastern Romanian cancer patients.
Negură L; Duşa CP; Balmuş MI; Azoicăi D; Negură AM; Marinca MV; Miron L
Rom J Morphol Embryol; 2015; 56(2):379-85. PubMed ID: 26193202
[TBL] [Abstract][Full Text] [Related]
11. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
14. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Ladopoulou A; Kroupis C; Konstantopoulou I; Ioannidou-Mouzaka L; Schofield AC; Pantazidis A; Armaou S; Tsiagas I; Lianidou E; Efstathiou E; Tsionou C; Panopoulos C; Mihalatos M; Nasioulas G; Skarlos D; Haites NE; Fountzilas G; Pandis N; Yannoukakos D
Cancer Lett; 2002 Nov; 185(1):61-70. PubMed ID: 12142080
[TBL] [Abstract][Full Text] [Related]
15. MUTATIONS OF GENES BRCA1 AND BRCA2 IN WOMEN WITH OVARIAN CANCER EXPOSED TO FACTORS OF CHORNOBYL NUCLEAR ACCIDENT.
Rybchenko LA; Poluben LO; Bychkova GM; Stephanovych GV; Klymenko SV
Probl Radiac Med Radiobiol; 2019 Dec; 24():455-464. PubMed ID: 31841487
[TBL] [Abstract][Full Text] [Related]
16. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
Hamel N; Feng BJ; Foretova L; Stoppa-Lyonnet D; Narod SA; Imyanitov E; Sinilnikova O; Tihomirova L; Lubinski J; Gronwald J; Gorski B; Hansen Tv; Nielsen FC; Thomassen M; Yannoukakos D; Konstantopoulou I; Zajac V; Ciernikova S; Couch FJ; Greenwood CM; Goldgar DE; Foulkes WD
Eur J Hum Genet; 2011 Mar; 19(3):300-6. PubMed ID: 21119707
[TBL] [Abstract][Full Text] [Related]
17. Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
Ossa CA; Torres D
Oncologist; 2016 Jul; 21(7):832-9. PubMed ID: 27286788
[TBL] [Abstract][Full Text] [Related]
18. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
[TBL] [Abstract][Full Text] [Related]
19. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
